Australia markets closed

Protalix BioTherapeutics, Inc. (PLX)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.1300-0.0500 (-4.24%)
At close: 04:00PM EDT
1.1400 +0.01 (+0.88%)
After hours: 07:47PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
23,634
17,111
38,985
18,265
-
Other short-term investments
20,926
5,069
0
20,280
-
Total cash
44,560
22,180
38,985
38,545
-
Net receivables
5,272
4,586
3,442
2,000
-
Inventory
19,045
16,804
17,954
13,082
-
Other current assets
611
536
380
819
-
Total current assets
69,932
44,880
61,666
55,723
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
45,570
43,326
42,674
42,335
-
Accumulated depreciation
-34,688
-33,686
-32,752
-31,923
-
Net property, plant and equipment
10,882
9,640
9,922
10,412
-
Total non-current assets
14,502
10,907
11,999
12,211
-
Total assets
84,434
55,787
73,665
67,934
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
20,251
-
-
58,513
4,301
Accounts payable
4,320
5,862
6,986
7,221
-
Taxes payable
2,876
530
-
-
-
Accrued liabilities
14,432
9,556
14,405
11,918
-
Deferred revenues
0
13,178
8,550
5,394
-
Total current liabilities
45,530
32,429
33,176
86,474
-
Non-current liabilities
Long-term debt
-
28,187
27,887
-
50,957
Deferred revenues
-
0
11,790
1,716
16,980
Other long-term liabilities
-
-
-
51
509
Total non-current liabilities
5,335
33,998
46,525
8,497
-
Total liabilities
50,865
66,427
79,701
94,971
-
Stockholders' equity
Common stock
73
54
46
35
-
Retained earnings
-381,549
-389,861
-374,934
-347,352
-
Total stockholders' equity
33,569
-10,640
-6,036
-27,037
-
Total liabilities and stockholders' equity
84,434
55,787
73,665
67,934
-